- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (11)
18 result(s) found for: Ticlopidine.
Displaying page 1 of 1.
EudraCT Number: 2010-020617-82 | Sponsor Protocol Number: TicloTrama_1.0 | Start Date*: 2010-08-12 | ||||||||||||||||
Sponsor Name:University of Turku | ||||||||||||||||||
Full Title: Effect of itraconazole and ticlopidine on the pharmacokinetics and pharmacodynamics of oral tramadol: A three-phase randomized balanced cross-over study in healthy volunteers | ||||||||||||||||||
Medical condition: Acute postoperative pain and chronic pain syndromes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-002251-41 | Sponsor Protocol Number: RE 001-2005 | Start Date*: 2005-03-22 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA ARCISPEDALE S. MARIA NUOVA | |||||||||||||
Full Title: ASTRA STUDY (Angioplasty, Stent X-ray Intensive Antithrombotic Therapy) A PHASE III, PROSPECTIVE AND RANDOMIZED, MULTICENTER STUDY, OPEN LABEL, PARALLEL-GROUP, BLINDED ADJUDICATION, TO INVESTIGATE ... | |||||||||||||
Medical condition: PAOD (Fontaine-Leriche St. IIb-IV)requiring percutaneous angioplasty with or without stenting | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002708-25 | Sponsor Protocol Number: RIVAROXACS3001 (BAY59-7939/13194) | Start Date*: 2008-11-27 | |||||||||||
Sponsor Name:Janssen-Cilag International N.V. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects with a Recent Acute Coronary Syndrome The ATLAS ACS 2 ... | |||||||||||||
Medical condition: Acute Coronary Syndrome (ACS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) LT (Completed) DE (Completed) PT (Completed) SK (Completed) HU (Completed) FR (Completed) DK (Completed) GB (Completed) NL (Completed) ES (Completed) IT (Completed) LV (Completed) CZ (Completed) BG (Completed) BE (Prematurely Ended) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005292-15 | Sponsor Protocol Number: H7T-MC-TABR & TABR (1) | Start Date*: 2006-03-02 | |||||||||||
Sponsor Name:Eli Lilly and Company Ltd. | |||||||||||||
Full Title: A Pharmacokinetic and Pharmacodynamic Comparison of Prasugrel (LY640315) versus Clopidogrel in Subjects with Stable Atherosclerosis | |||||||||||||
Medical condition: Stable atherosclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001135-35 | Sponsor Protocol Number: TMC-CAN-08-02 | Start Date*: 2010-02-02 | |||||||||||||||||||||
Sponsor Name:The Medicines Company | |||||||||||||||||||||||
Full Title: Maintenance of platelet inhiBition with cangreloR after dIscontinuation of thienopyriDines in patients undergoing surGEry: The BRIDGE trial | |||||||||||||||||||||||
Medical condition: Subjects who present with an acute coronary syndrome. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: CZ (Completed) GB (Completed) AT (Completed) NL (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-001250-91 | Sponsor Protocol Number: GV-002.001 | Start Date*: 2005-10-04 |
Sponsor Name:GenVec, Inc. | ||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy of BIOBYPASS® (ADGVVEGF121.10NH) Delivered by NOGA-Guided/MYOSTAR Catheter in "No Option" Patients with Cla... | ||
Medical condition: Moderate to severe angina pectoris due to advanced coronary artery disease (CAD). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) AT (Completed) DE (Completed) GB (Completed) BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001201-27 | Sponsor Protocol Number: P07038 | Start Date*: 2011-11-07 |
Sponsor Name:Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., USA | ||
Full Title: A randomized, controlled, parallel-group, double-blind trial of sugammadex or usual care (neostigmine or spontaneous recovery) for reversal of rocuronium- or vecuronium-induced neuromuscular blocka... | ||
Medical condition: not applicable | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) BE (Completed) NL (Prematurely Ended) AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-003590-24 | Sponsor Protocol Number: LPL104884 | Start Date*: 2006-03-01 |
Sponsor Name:GlaxoSmithKline Research & Development Limited | ||
Full Title: LPL104884: A multicenter, randomized, double-blind, placebocontrolled, parallel-group, dose-ranging study of SB-480848, an oral lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, in subje... | ||
Medical condition: SB-480848 is under developement as a potential anti-atherosclerosis agent for reduction of major cardiovascular events in high risk patient populations. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) ES (Completed) EE (Completed) HU (Completed) DE (Completed) DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-001129-34 | Sponsor Protocol Number: AG-CLI-0206 | Start Date*: 2014-11-24 | |||||||||||
Sponsor Name:AnGes Inc. | |||||||||||||
Full Title: A PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF AMG0001 IN SUBJECTS WITH CRITICAL LIMB ISCHEMIA | |||||||||||||
Medical condition: Critical limb ischemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) FI (Prematurely Ended) IT (Prematurely Ended) DK (Prematurely Ended) BE (Prematurely Ended) HU (Completed) NL (Prematurely Ended) PL (Prematurely Ended) ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-006029-94 | Sponsor Protocol Number: E5555-G000-201 | Start Date*: 2008-01-23 | |||||||||||
Sponsor Name:Eisai Limited | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Tolerability of E5555, and its Effects on Markers of Intravascular Inflammation in Subjects with Coronary Artery Disease | |||||||||||||
Medical condition: Coronary Artery Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) DE (Completed) BE (Completed) NL (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001676-21 | Sponsor Protocol Number: P141102 | Start Date*: 2016-12-19 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Anti-Thrombotic Strategy to Lower All Cardiovascular and Neurologic Ischemic and Hemorrhagic Events after Trans-Aortic Valve Implantation for Aortic Stenosis: The ATLANTIS trial | |||||||||||||
Medical condition: Patients who underwent a clinically successful TAVI procedure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000475-27 | Sponsor Protocol Number: I14041 | Start Date*: 2015-07-29 | |||||||||||
Sponsor Name:CHU de Limoges | |||||||||||||
Full Title: Multicenter phase II trial of Nintedanib plus docetaxel in second line of treatment in patients with no squamous non small cell lung cancer refractory to first line chemotherapy (REFRACT study) | |||||||||||||
Medical condition: No squamous non small cell lung | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004446-42 | Sponsor Protocol Number: MB11-2018 | Start Date*: 2019-06-20 | |||||||||||
Sponsor Name:AZIENDA SANITARIA OSPEDALIERA S.CROCE E CARLE CUNEO | |||||||||||||
Full Title: Maintenance Of aNtiplatElet Therapy in patients with coronary stenting undergoing surgery | |||||||||||||
Medical condition: Patients a least 18 years of age on DAPT per standard of care who are planned to undergo non deferrable cardiac and non cardiac surgery which will require discontinuation of a P2Y12 inhibitor. Subj... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-005532-18 | Sponsor Protocol Number: PLX-CLI-03 | Start Date*: 2017-01-02 | |||||||||||
Sponsor Name:Pluristem Ltd. | |||||||||||||
Full Title: A Randomized, Double-Blind, Multicenter, Placebo-Controlled, Parallel-Group Phase III Study to Evaluate the Efficacy, Tolerability and Safety of Intramuscular Injections of PLX-PAD for the Treatmen... | |||||||||||||
Medical condition: Critical Limb Ischemia (CLI) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) CZ (Prematurely Ended) AT (Completed) HU (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001341-14 | Sponsor Protocol Number: BAY 59-7939 / 11527 | Start Date*: 2004-11-04 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: Controlled, Double-Blind, Randomized, Dose-ranging Study of once-daily regimen of BAY59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement-ODIXaHIP-OD Study | |||||||||||||
Medical condition: Deep Venous Thrombosis prophylaxis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) AT (Completed) ES (Completed) GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004301-99 | Sponsor Protocol Number: 1160.67 | Start Date*: 2008-02-06 | |||||||||||
Sponsor Name:Boehringer Ingelheim AB | |||||||||||||
Full Title: RandomisEd Dabigatran Etexilate dose finding study in patients with acute coronary syndromes post index Event with additional risk factors for cardiovascular complications also receiving aspirin an... | |||||||||||||
Medical condition: Acute coronary syndromes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DK (Completed) FI (Completed) DE (Completed) ES (Completed) BE (Completed) GB (Completed) IE (Completed) CZ (Completed) HU (Completed) FR (Completed) PL (Completed) BG (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000046-19 | Sponsor Protocol Number: RIVAROXHFA3001/BAY59-7939/16302 | Start Date*: 2013-08-23 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Oral Rivaroxaban with Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Sub... | |||||||||||||
Medical condition: Prevention of death, heart attack and stroke in patients with chronic heart failure and significant coronary artery disease following a hospitalization for exacerbation of heart failure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) CZ (Completed) DE (Completed) NL (Completed) BG (Completed) PL (Completed) HU (Completed) SE (Completed) IT (Completed) GB (Completed) EE (Completed) LT (Completed) PT (Completed) DK (Completed) LV (Completed) SK (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002147-91 | Sponsor Protocol Number: CV185-030 | Start Date*: 2007-05-14 | ||||||||||||||||
Sponsor Name:Bristol Myers Squibb International Corporation | ||||||||||||||||||
Full Title: A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalv... | ||||||||||||||||||
Medical condition: ARRHYTHMIA; THROMBOSIS | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) NO (Completed) BE (Completed) FI (Completed) ES (Completed) DK (Completed) HU (Completed) AT (Completed) CZ (Completed) FR (Completed) DE (Completed) IT (Completed) NL (Completed) GB (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.